KRAS and lung carcinoma: To investigate the inhibitory effects of MA in lung cancer cells, we treated different types of lung cancer cells, including KRAS-mutated lung cancer cell lines A549 and H157 and EGFR-mutated lung cancer cell lines HCC827 and PC9, with different concentrations of MA for 48 and 72 h.